Cargando…

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab

Severe asthma in children and adolescents exerts a substantial health, financial, and societal burden. Severe asthma is a heterogeneous condition with multiple clinical phenotypes and underlying inflammatory patterns that might be different in individual patients. Various add-on treatments have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Yoni E., Rutjes, Niels W., Golebski, Korneliusz, Şahin, Havva, Hashimoto, Simone, Maitland-van der Zee, Anke-Hilse, Vijverberg, Susanne J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600295/ https://www.ncbi.nlm.nih.gov/pubmed/37658954 http://dx.doi.org/10.1007/s40272-023-00589-4

Ejemplares similares

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Childhood asthma in the new omics era: challenges and perspectives
por: Golebski, Korneliusz, et al.
Publicado: (2020)

Precision medicine in severe pediatric asthma: opportunities and challenges
por: Vijverberg, Susanne J.H., et al.
Publicado: (2020)

Treating severe asthma: Targeting the IL‐5 pathway
por: Principe, Stefania, et al.
Publicado: (2021)

Expert meeting report: towards a joint European roadmap to address the unmet needs and priorities of paediatric asthma patients on biologic therapy
por: Golebski, Korneliusz, et al.
Publicado: (2021)

Clinical utility of asthma biomarkers: from bench to bedside
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
por: Cheng, Shih-Lung
Publicado: (2021)

Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
por: Plaza, Vicente, et al.
Publicado: (2023)

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
por: Langley, Paul C
Publicado: (2022)

Inflammatory phenotypes underlying uncontrolled childhood asthma despite inhaled corticosteroid treatment: rationale and design of the PACMAN2 study
por: Vijverberg, Susanne JH, et al.
Publicado: (2013)

Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations
por: van Bragt, Job J. M. H., et al.
Publicado: (2021)

Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint (the pacman2 study)
por: Vijverberg, Susanne, et al.
Publicado: (2015)

The crosstalk between microbiome and asthma: Exploring associations and challenges
por: Abdel‐Aziz, Mahmoud I., et al.
Publicado: (2019)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
por: Dorey-Stein, Zachariah L, et al.
Publicado: (2021)

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma
por: Corren, Jonathan, et al.
Publicado: (2022)

The potential promise and challenge for tezepelumab as a biologic therapy for severe asthma
por: Williams, Dennis M
Publicado: (2022)

Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
por: Zoumot, Zaid, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
por: Laidlaw, Tanya M, et al.
Publicado: (2023)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
por: Zazuli, Zulfan, et al.
Publicado: (2018)

Characteristics and severity of asthma in children with and without atopic conditions: a cross-sectional study
por: Arabkhazaeli, Ali, et al.
Publicado: (2015)

Tezepelumab treatment for allergic bronchopulmonary aspergillosis
por: Ogata, Hiroaki, et al.
Publicado: (2023)

The Impact of Tezepelumab in Uncontrolled Severe Asthma: A Systematic Review of Randomized Controlled Trials
por: Roy, Pooja, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Publicado: (2023)

Genetic associations of the response to inhaled corticosteroids in asthma: a systematic review
por: Keskin, Ozlem, et al.
Publicado: (2019)

Persistence of parental‐reported asthma at early ages: A longitudinal twin study
por: Slob, Elise Margaretha Adriana, et al.
Publicado: (2022)

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010)

IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids
por: Dijk, F. Nicole, et al.
Publicado: (2019)

The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients
por: Principe, Stefania, et al.
Publicado: (2021)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

Adolescents' experiences with patient engagement in respiratory medicine
por: Groot, Barbara, et al.
Publicado: (2020)

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2020)

The Role of Dupilumab in Severe Asthma
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma
por: Alpizar, Sady, et al.
Publicado: (2021)

The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: A systematic review and meta-analysis of randomized controlled trials
por: Lin, Fei, et al.
Publicado: (2023)

Characteristics of severe asthma patients on biologics: a real-life European registry study
por: Principe, Stefania, et al.
Publicado: (2023)

Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis
por: Shaban Abdelgalil, Mahmoud, et al.
Publicado: (2022)

Dupilumab: a novel treatment for asthma
por: Vatrella, Alessandro, et al.
Publicado: (2014)

Severe pediatric asthma therapy: Dupilumab
por: Ferrante, Giuliana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a7uk2nrmg4qq6ju9pc1ub70smu